376 related articles for article (PubMed ID: 15217933)
21. Synchronous endometrioid carcinomas of the uterine corpus and ovary: alterations in the beta-catenin (CTNNB1) pathway are associated with independent primary tumors and favorable prognosis.
Irving JA; Catasús L; Gallardo A; Bussaglia E; Romero M; Matias-Guiu X; Prat J
Hum Pathol; 2005 Jun; 36(6):605-19. PubMed ID: 16021566
[TBL] [Abstract][Full Text] [Related]
22. Microsatellite instability and somatic mutations in endometrial carcinomas.
Sakamoto T; Murase T; Urushibata H; Kato K; Takada H; Imamura T; Mori H; Wake N
Gynecol Oncol; 1998 Oct; 71(1):53-8. PubMed ID: 9784319
[TBL] [Abstract][Full Text] [Related]
23. The frequency of p53, K-ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma: evidence of distinct molecular genetic pathways.
Lax SF; Kendall B; Tashiro H; Slebos RJ; Hedrick L
Cancer; 2000 Feb; 88(4):814-24. PubMed ID: 10679651
[TBL] [Abstract][Full Text] [Related]
24. Fat and K-ras mutations in sporadic colorectal cancer in The Netherlands Cohort Study.
Brink M; Weijenberg MP; De Goeij AF; Schouten LJ; Koedijk FD; Roemen GM; Lentjes MH; De Bruïne AP; Goldbohm RA; Van Den Brandt PA
Carcinogenesis; 2004 Sep; 25(9):1619-28. PubMed ID: 15117813
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of TP53 and K-ras-2 mutational analysis in stage III carcinoma of the colon.
Pricolo VE; Finkelstein SD; Wu TT; Keller G; Bakker A; Swalsky PA; Bland KI
Am J Surg; 1996 Jan; 171(1):41-6. PubMed ID: 8554149
[TBL] [Abstract][Full Text] [Related]
26. Sporadic fundic gland polyps with epithelial dysplasia : evidence for preferential targeting for mutations in the adenomatous polyposis coli gene.
Abraham SC; Park SJ; Mugartegui L; Hamilton SR; Wu TT
Am J Pathol; 2002 Nov; 161(5):1735-42. PubMed ID: 12414520
[TBL] [Abstract][Full Text] [Related]
27. Distinct K-ras mutation pattern characterizes signet ring cell colorectal carcinoma.
Wistuba II; Behrens C; Albores-Saavedra J; Delgado R; Lopez F; Gazdar AF
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3615-9. PubMed ID: 14506148
[TBL] [Abstract][Full Text] [Related]
28. [Genetic alterations of human colorectal cancer].
Suzuki T; Ishioka C; Gamo M; Niitani T; Shimodaira H; Kanbe M; Yamazaki T; Yusa Y; Kanamaru R
Gan To Kagaku Ryoho; 1994 Feb; 21(3):343-50. PubMed ID: 8109990
[TBL] [Abstract][Full Text] [Related]
29. Genetic analysis of radiation-associated rectal cancer.
Tsuji T; Sawai T; Nakagoe T; Hidaka S; Shibasaki S; Tanaka K; Nanashima A; Yamaguchi H; Yasutake T; Tagawa Y
J Gastroenterol; 2003; 38(12):1185-8. PubMed ID: 14714259
[TBL] [Abstract][Full Text] [Related]
30. Mutations in APC, Kirsten-ras, and p53--alternative genetic pathways to colorectal cancer.
Smith G; Carey FA; Beattie J; Wilkie MJ; Lightfoot TJ; Coxhead J; Garner RC; Steele RJ; Wolf CR
Proc Natl Acad Sci U S A; 2002 Jul; 99(14):9433-8. PubMed ID: 12093899
[TBL] [Abstract][Full Text] [Related]
31. Frequent mutations of the Trp53, Hras1 and beta-catenin (Catnb) genes in 1,3-butadiene-induced mammary adenocarcinomas in B6C3F1 mice.
Zhuang SM; Wiseman RW; Söderkvist P
Oncogene; 2002 Aug; 21(36):5643-8. PubMed ID: 12165863
[TBL] [Abstract][Full Text] [Related]
32. The capacity for growth stimulation by TGF beta 1 seen only in advanced colon cancers cannot be ascribed to mutations in APC, DCC, p53 or ras.
Huang F; Hsu S; Yan Z; Winawer S; Friedman E
Oncogene; 1994 Dec; 9(12):3701-6. PubMed ID: 7970729
[TBL] [Abstract][Full Text] [Related]
33. APC gene loss of heterozygosity, mutations, E1317Q, and I1307K germ-line variants in sporadic colon cancer in Croatia.
Kapitanović S; Cacev T; Radosević S; Spaventi S; Spaventi R; Pavelić K
Exp Mol Pathol; 2004 Dec; 77(3):193-200. PubMed ID: 15507235
[TBL] [Abstract][Full Text] [Related]
34. Mutation of p53 and K-ras, and loss of heterozygosity of APC in intrahepatic cholangiocarcinoma.
Kang YK; Kim WH; Lee HW; Lee HK; Kim YI
Lab Invest; 1999 Apr; 79(4):477-83. PubMed ID: 10212000
[TBL] [Abstract][Full Text] [Related]
35. Molecular genetics of ulcerative colitis-associated colon cancer in the interleukin 2- and beta(2)-microglobulin-deficient mouse.
Sohn KJ; Shah SA; Reid S; Choi M; Carrier J; Comiskey M; Terhorst C; Kim YI
Cancer Res; 2001 Sep; 61(18):6912-7. PubMed ID: 11559569
[TBL] [Abstract][Full Text] [Related]
36. Genetic alterations in gastric adenomas of intestinal and foveolar phenotypes.
Abraham SC; Park SJ; Lee JH; Mugartegui L; Wu TT
Mod Pathol; 2003 Aug; 16(8):786-95. PubMed ID: 12920223
[TBL] [Abstract][Full Text] [Related]
37. Analysis of somatic APC mutations in rare extracolonic tumors of patients with familial adenomatous polyposis coli.
Bläker H; Sutter C; Kadmon M; Otto HF; Von Knebel-Doeberitz M; Gebert J; Helmke BM
Genes Chromosomes Cancer; 2004 Oct; 41(2):93-8. PubMed ID: 15287021
[TBL] [Abstract][Full Text] [Related]
38. Exon 3 beta-catenin mutations are specifically associated with colorectal carcinomas in hereditary non-polyposis colorectal cancer syndrome.
Johnson V; Volikos E; Halford SE; Eftekhar Sadat ET; Popat S; Talbot I; Truninger K; Martin J; Jass J; Houlston R; Atkin W; Tomlinson IP; Silver AR
Gut; 2005 Feb; 54(2):264-7. PubMed ID: 15647192
[TBL] [Abstract][Full Text] [Related]
39. Loss of heterozygosity in human aberrant crypt foci (ACF), a putative precursor of colon cancer.
Luo L; Shen GQ; Stiffler KA; Wang QK; Pretlow TG; Pretlow TP
Carcinogenesis; 2006 Jun; 27(6):1153-9. PubMed ID: 16474178
[TBL] [Abstract][Full Text] [Related]
40. Impact of KRAS and TP53 mutations on survival in patients with left- and right-sided Dukes' C colon cancer.
Bleeker WA; Hayes VM; Karrenbeld A; Hofstra RM; Hermans J; Buys CC; Plukker JT
Am J Gastroenterol; 2000 Oct; 95(10):2953-7. PubMed ID: 11051374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
